Cardinal Point Capital Management ULC bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 3rd quarter, Holdings Channel reports. The institutional investor bought 3,507 shares of the semiconductor company’s stock, valued at approximately $1,730,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Alpine Bank Wealth Management boosted its stake in Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares in the last quarter. TFC Financial Management Inc. raised its holdings in shares of Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after buying an additional 50 shares during the last quarter. Millstone Evans Group LLC acquired a new stake in shares of Synopsys during the third quarter worth $27,000. SOA Wealth Advisors LLC. acquired a new stake in shares of Synopsys during the third quarter worth $28,000. Finally, McIlrath & Eck LLC purchased a new stake in shares of Synopsys during the third quarter valued at $29,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
SNPS has been the subject of a number of research analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Thursday, January 22nd. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Citigroup initiated coverage on Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 target price for the company. Morgan Stanley increased their price target on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Finally, KeyCorp raised their price target on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $553.57.
Insider Buying and Selling
In other news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 4,157 shares of company stock worth $1,945,036 over the last quarter. 0.62% of the stock is currently owned by insiders.
Synopsys Stock Up 4.0%
Synopsys stock opened at $426.88 on Monday. The stock has a market capitalization of $81.67 billion, a PE ratio of 53.43, a price-to-earnings-growth ratio of 3.56 and a beta of 1.12. The business has a 50 day simple moving average of $479.33 and a 200-day simple moving average of $495.06. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business’s revenue was up 37.8% on a year-over-year basis. During the same period in the previous year, the company posted $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- The day the gold market broke
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- He just nailed another gold prediction …
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
